Carmela Hoefling Discusses Effects of Malnutrition During Surgery

​Carmela Hoefling, RN, MSN, APN-C, AOCNP
Published: Thursday, Apr 28, 2016



Carmela Hoefling, RN, MSN, APN-C, AOCNP, advanced practice nurse, Gastrointestinal/Hepatobiliary Oncology Program, Rutgers Cancer Institute of New Jersey, discusses the effects that malnourishment can have on surgery.

Malnourishment, which is a 10% loss of body weight within 6 months, is a common issue that patients with cancer face. When they go into surgery, patients who are malnourished tend to have longer hospital stays, prolonged recovery, and a higher rate of infection.

Hoefling found that correcting the malnourishment before surgery leads to better outcomes. However, this is not always a matter of simply feeding the patient. While some patients may be able to eat normally, others need to take their nourishment in different forms, such as in an IV form.
For more information, visit Nursing.OncLive.com.

<<< View more from the 2016 ONS Annual Congress



Carmela Hoefling, RN, MSN, APN-C, AOCNP, advanced practice nurse, Gastrointestinal/Hepatobiliary Oncology Program, Rutgers Cancer Institute of New Jersey, discusses the effects that malnourishment can have on surgery.

Malnourishment, which is a 10% loss of body weight within 6 months, is a common issue that patients with cancer face. When they go into surgery, patients who are malnourished tend to have longer hospital stays, prolonged recovery, and a higher rate of infection.

Hoefling found that correcting the malnourishment before surgery leads to better outcomes. However, this is not always a matter of simply feeding the patient. While some patients may be able to eat normally, others need to take their nourishment in different forms, such as in an IV form.
For more information, visit Nursing.OncLive.com.

<<< View more from the 2016 ONS Annual Congress


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x